These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 17211010)

  • 1. Reducing the growing burden of cardiovascular disease in the developing world.
    Gaziano TA
    Health Aff (Millwood); 2007; 26(1):13-24. PubMed ID: 17211010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing the global burden of cardiovascular disease: the role of risk factors.
    Levenson JW; Skerrett PJ; Gaziano JM
    Prev Cardiol; 2002; 5(4):188-99. PubMed ID: 12417828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications.
    Gersh BJ; Sliwa K; Mayosi BM; Yusuf S
    Eur Heart J; 2010 Mar; 31(6):642-8. PubMed ID: 20176800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time for results: a better way to reduce cardiovascular risk.
    Mola A; Lloyd M
    Adv Nurse Pract; 2002 Apr; 10(4):34-41; quiz 42-3. PubMed ID: 12418348
    [No Abstract]   [Full Text] [Related]  

  • 5. Challenges for the management of hypertension in low-resource settings.
    Mendis S
    Ethn Dis; 2003; 13(2 Suppl 2):S67-70. PubMed ID: 13677416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for cardiovascular disease in Canada.
    Tanuseputro P; Manuel DG; Leung M; Nguyen K; Johansen H;
    Can J Cardiol; 2003 Oct; 19(11):1249-59. PubMed ID: 14571310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges and opportunities for cardiovascular disease prevention.
    Franco M; Cooper RS; Bilal U; Fuster V
    Am J Med; 2011 Feb; 124(2):95-102. PubMed ID: 21295188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The global epidemiology of heart failure.
    Young JB
    Med Clin North Am; 2004 Sep; 88(5):1135-43, ix. PubMed ID: 15331310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular disease 2005--the global picture.
    Callow AD
    Vascul Pharmacol; 2006 Nov; 45(5):302-7. PubMed ID: 17074537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can we prevent cardiovascular diseases in low- and middle-income countries?
    Lenfant C
    Bull World Health Organ; 2001; 79(10):980-2; discussion 983-7. PubMed ID: 11693981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention of cardiovascular disease].
    Rev Infirm; 2006 Mar; (119):16-23. PubMed ID: 16625779
    [No Abstract]   [Full Text] [Related]  

  • 12. Review of community-based interventions for prevention of cardiovascular diseases in low- and middle-income countries.
    van de Vijver S; Oti S; Addo J; de Graft-Aikins A; Agyemang C
    Ethn Health; 2012; 17(6):651-76. PubMed ID: 23297746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging economies and diabetes and cardiovascular disease.
    Pradeepa R; Prabhakaran D; Mohan V
    Diabetes Technol Ther; 2012 Jun; 14 Suppl 1():S59-67. PubMed ID: 22650226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. World Heart Day 2002: the international burden of cardiovascular disease: responding to the emerging global epidemic.
    Bonow RO; Smaha LA; Smith SC; Mensah GA; Lenfant C
    Circulation; 2002 Sep; 106(13):1602-5. PubMed ID: 12270848
    [No Abstract]   [Full Text] [Related]  

  • 15. A Global Perspective on Cardiovascular Disease in Vulnerable Populations.
    Yeates K; Lohfeld L; Sleeth J; Morales F; Rajkotia Y; Ogedegbe O
    Can J Cardiol; 2015 Sep; 31(9):1081-93. PubMed ID: 26321432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Burden of Cardiovascular Disease in Low- and Middle-Income Countries: Epidemiology and Management.
    Bowry AD; Lewey J; Dugani SB; Choudhry NK
    Can J Cardiol; 2015 Sep; 31(9):1151-9. PubMed ID: 26321437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are the current recommendations for the use of aspirin in primary prevention of cardiovascular disease applicable in low-income countries?
    Noubiap JJ; Nansseu JR
    Vasc Health Risk Manag; 2015; 11():503-6. PubMed ID: 26345154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and public health policy of tobacco use and cardiovascular disorders in low- and middle-income countries.
    Saleheen D; Zhao W; Rasheed A
    Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):1811-9. PubMed ID: 25035346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The burden and costs of chronic diseases in low-income and middle-income countries.
    Abegunde DO; Mathers CD; Adam T; Ortegon M; Strong K
    Lancet; 2007 Dec; 370(9603):1929-38. PubMed ID: 18063029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tobacco use and the cardiovascular disease epidemic in developing countries: global crises and opportunity in the making.
    Asma S; Mensah GA; Warren CW; Henson R
    Ethn Dis; 2003; 13(2 Suppl 2):S81-7. PubMed ID: 13677419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.